nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Desmopressin—PTGS1—kidney cancer	0.00305	0.636	CrCbGaD
Pasireotide—Abdominal pain upper—Paclitaxel—kidney cancer	0.00203	0.00236	CcSEcCtD
Pasireotide—Anxiety—Everolimus—kidney cancer	0.00203	0.00235	CcSEcCtD
Pasireotide—Hypokalaemia—Paclitaxel—kidney cancer	0.00203	0.00235	CcSEcCtD
Pasireotide—Alopecia—Sunitinib—kidney cancer	0.00203	0.00235	CcSEcCtD
Pasireotide—Gastrointestinal pain—Pazopanib—kidney cancer	0.00202	0.00234	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Paclitaxel—kidney cancer	0.00201	0.00232	CcSEcCtD
Pasireotide—Nasopharyngitis—Paclitaxel—kidney cancer	0.00199	0.00231	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Paclitaxel—kidney cancer	0.00196	0.00228	CcSEcCtD
Pasireotide—Arthralgia—Erlotinib—kidney cancer	0.00196	0.00227	CcSEcCtD
Pasireotide—Myalgia—Erlotinib—kidney cancer	0.00196	0.00227	CcSEcCtD
Pasireotide—Anxiety—Erlotinib—kidney cancer	0.00196	0.00227	CcSEcCtD
Pasireotide—Abdominal pain—Pazopanib—kidney cancer	0.00195	0.00226	CcSEcCtD
Pasireotide—Abdominal distension—Paclitaxel—kidney cancer	0.00194	0.00224	CcSEcCtD
Pasireotide—Back pain—Sunitinib—kidney cancer	0.00193	0.00224	CcSEcCtD
Pasireotide—Influenza—Paclitaxel—kidney cancer	0.00193	0.00223	CcSEcCtD
Pasireotide—Alopecia—Dactinomycin—kidney cancer	0.00192	0.00222	CcSEcCtD
Pasireotide—Anaemia—Sorafenib—kidney cancer	0.00192	0.00222	CcSEcCtD
Pasireotide—Asthenia—Temsirolimus—kidney cancer	0.00188	0.00218	CcSEcCtD
Pasireotide—Pruritus—Temsirolimus—kidney cancer	0.00186	0.00215	CcSEcCtD
Pasireotide—Anaemia—Sunitinib—kidney cancer	0.00185	0.00214	CcSEcCtD
Pasireotide—Pain in extremity—Capecitabine—kidney cancer	0.00183	0.00212	CcSEcCtD
Pasireotide—Hypotension—Everolimus—kidney cancer	0.00182	0.00211	CcSEcCtD
Pasireotide—Oedema peripheral—Gemcitabine—kidney cancer	0.00181	0.0021	CcSEcCtD
Pasireotide—Diarrhoea—Temsirolimus—kidney cancer	0.00179	0.00208	CcSEcCtD
Pasireotide—Hypertension—Sorafenib—kidney cancer	0.00179	0.00208	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Everolimus—kidney cancer	0.00178	0.00206	CcSEcCtD
Pasireotide—Asthenia—Pazopanib—kidney cancer	0.00177	0.00205	CcSEcCtD
Pasireotide—Arthralgia—Sorafenib—kidney cancer	0.00177	0.00205	CcSEcCtD
Pasireotide—Myalgia—Sorafenib—kidney cancer	0.00177	0.00205	CcSEcCtD
Pasireotide—Insomnia—Everolimus—kidney cancer	0.00176	0.00204	CcSEcCtD
Pasireotide—Pruritus—Pazopanib—kidney cancer	0.00175	0.00202	CcSEcCtD
Pasireotide—Anaemia—Dactinomycin—kidney cancer	0.00175	0.00202	CcSEcCtD
Pasireotide—Desmopressin—PTGS2—kidney cancer	0.00175	0.364	CrCbGaD
Pasireotide—Hyperglycaemia—Paclitaxel—kidney cancer	0.00174	0.00201	CcSEcCtD
Pasireotide—Dizziness—Temsirolimus—kidney cancer	0.00173	0.00201	CcSEcCtD
Pasireotide—Hypertension—Sunitinib—kidney cancer	0.00172	0.002	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.00172	0.00199	CcSEcCtD
Pasireotide—Alopecia—Vincristine—kidney cancer	0.00171	0.00199	CcSEcCtD
Pasireotide—Insomnia—Erlotinib—kidney cancer	0.0017	0.00197	CcSEcCtD
Pasireotide—Decreased appetite—Vinblastine—kidney cancer	0.0017	0.00197	CcSEcCtD
Pasireotide—Myalgia—Sunitinib—kidney cancer	0.0017	0.00197	CcSEcCtD
Pasireotide—Arthralgia—Sunitinib—kidney cancer	0.0017	0.00197	CcSEcCtD
Pasireotide—Decreased appetite—Everolimus—kidney cancer	0.0017	0.00196	CcSEcCtD
Pasireotide—Diarrhoea—Pazopanib—kidney cancer	0.00169	0.00196	CcSEcCtD
Pasireotide—Fatigue—Everolimus—kidney cancer	0.00168	0.00195	CcSEcCtD
Pasireotide—Dry skin—Capecitabine—kidney cancer	0.00168	0.00194	CcSEcCtD
Pasireotide—Constipation—Vinblastine—kidney cancer	0.00167	0.00194	CcSEcCtD
Pasireotide—Abdominal pain upper—Capecitabine—kidney cancer	0.00167	0.00193	CcSEcCtD
Pasireotide—Constipation—Everolimus—kidney cancer	0.00167	0.00193	CcSEcCtD
Pasireotide—Vomiting—Temsirolimus—kidney cancer	0.00167	0.00193	CcSEcCtD
Pasireotide—Hypokalaemia—Capecitabine—kidney cancer	0.00166	0.00193	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.00165	0.00191	CcSEcCtD
Pasireotide—Headache—Temsirolimus—kidney cancer	0.00164	0.0019	CcSEcCtD
Pasireotide—Decreased appetite—Erlotinib—kidney cancer	0.00164	0.0019	CcSEcCtD
Pasireotide—Nasopharyngitis—Capecitabine—kidney cancer	0.00163	0.00189	CcSEcCtD
Pasireotide—Dizziness—Pazopanib—kidney cancer	0.00163	0.00189	CcSEcCtD
Pasireotide—Back pain—Vincristine—kidney cancer	0.00163	0.00189	CcSEcCtD
Pasireotide—Alopecia—Gemcitabine—kidney cancer	0.00163	0.00188	CcSEcCtD
Pasireotide—Fatigue—Erlotinib—kidney cancer	0.00162	0.00188	CcSEcCtD
Pasireotide—Injection site reaction—Doxorubicin—kidney cancer	0.00161	0.00187	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Capecitabine—kidney cancer	0.00161	0.00187	CcSEcCtD
Pasireotide—Constipation—Erlotinib—kidney cancer	0.00161	0.00186	CcSEcCtD
Pasireotide—Myalgia—Dactinomycin—kidney cancer	0.00161	0.00186	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vinblastine—kidney cancer	0.0016	0.00185	CcSEcCtD
Pasireotide—Gastrointestinal pain—Everolimus—kidney cancer	0.0016	0.00185	CcSEcCtD
Pasireotide—Abdominal distension—Capecitabine—kidney cancer	0.00159	0.00184	CcSEcCtD
Pasireotide—Influenza—Capecitabine—kidney cancer	0.00158	0.00183	CcSEcCtD
Pasireotide—Vomiting—Pazopanib—kidney cancer	0.00157	0.00182	CcSEcCtD
Pasireotide—Anaemia—Vincristine—kidney cancer	0.00156	0.00181	CcSEcCtD
Pasireotide—Nausea—Temsirolimus—kidney cancer	0.00156	0.0018	CcSEcCtD
Pasireotide—Back pain—Gemcitabine—kidney cancer	0.00155	0.00179	CcSEcCtD
Pasireotide—Abdominal pain—Vinblastine—kidney cancer	0.00155	0.00179	CcSEcCtD
Pasireotide—Headache—Pazopanib—kidney cancer	0.00155	0.00179	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.00154	0.00179	CcSEcCtD
Pasireotide—Abdominal pain—Everolimus—kidney cancer	0.00154	0.00179	CcSEcCtD
Pasireotide—Gastrointestinal pain—Erlotinib—kidney cancer	0.00154	0.00178	CcSEcCtD
Pasireotide—Oedema peripheral—Paclitaxel—kidney cancer	0.00152	0.00176	CcSEcCtD
Pasireotide—Vertigo—Vincristine—kidney cancer	0.00152	0.00176	CcSEcCtD
Pasireotide—Abdominal pain—Erlotinib—kidney cancer	0.00149	0.00172	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.00148	0.00172	CcSEcCtD
Pasireotide—Anaemia—Gemcitabine—kidney cancer	0.00148	0.00172	CcSEcCtD
Pasireotide—Insomnia—Sunitinib—kidney cancer	0.00147	0.00171	CcSEcCtD
Pasireotide—Decreased appetite—Sorafenib—kidney cancer	0.00147	0.00171	CcSEcCtD
Pasireotide—Nausea—Pazopanib—kidney cancer	0.00147	0.0017	CcSEcCtD
Pasireotide—Fatigue—Sorafenib—kidney cancer	0.00146	0.00169	CcSEcCtD
Pasireotide—Hypertension—Vincristine—kidney cancer	0.00146	0.00169	CcSEcCtD
Pasireotide—Constipation—Sorafenib—kidney cancer	0.00145	0.00168	CcSEcCtD
Pasireotide—Myalgia—Vincristine—kidney cancer	0.00144	0.00167	CcSEcCtD
Pasireotide—Hyperglycaemia—Capecitabine—kidney cancer	0.00143	0.00165	CcSEcCtD
Pasireotide—Decreased appetite—Sunitinib—kidney cancer	0.00142	0.00164	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00141	0.00163	CcSEcCtD
Pasireotide—Asthenia—Vinblastine—kidney cancer	0.00141	0.00163	CcSEcCtD
Pasireotide—Fatigue—Sunitinib—kidney cancer	0.00141	0.00163	CcSEcCtD
Pasireotide—Asthenia—Everolimus—kidney cancer	0.0014	0.00162	CcSEcCtD
Pasireotide—Constipation—Sunitinib—kidney cancer	0.00139	0.00161	CcSEcCtD
Pasireotide—Gastrointestinal pain—Sorafenib—kidney cancer	0.00138	0.0016	CcSEcCtD
Pasireotide—Hypertension—Gemcitabine—kidney cancer	0.00138	0.0016	CcSEcCtD
Pasireotide—Pruritus—Everolimus—kidney cancer	0.00138	0.0016	CcSEcCtD
Pasireotide—Myalgia—Gemcitabine—kidney cancer	0.00136	0.00158	CcSEcCtD
Pasireotide—Arthralgia—Gemcitabine—kidney cancer	0.00136	0.00158	CcSEcCtD
Pasireotide—Alopecia—Paclitaxel—kidney cancer	0.00136	0.00158	CcSEcCtD
Pasireotide—Diabetes mellitus—Doxorubicin—kidney cancer	0.00135	0.00157	CcSEcCtD
Pasireotide—Asthenia—Erlotinib—kidney cancer	0.00135	0.00156	CcSEcCtD
Pasireotide—Decreased appetite—Dactinomycin—kidney cancer	0.00134	0.00155	CcSEcCtD
Pasireotide—Diarrhoea—Vinblastine—kidney cancer	0.00134	0.00155	CcSEcCtD
Pasireotide—Abdominal pain—Sorafenib—kidney cancer	0.00134	0.00155	CcSEcCtD
Pasireotide—Diarrhoea—Everolimus—kidney cancer	0.00134	0.00155	CcSEcCtD
Pasireotide—Gastrointestinal pain—Sunitinib—kidney cancer	0.00133	0.00154	CcSEcCtD
Pasireotide—Pruritus—Erlotinib—kidney cancer	0.00133	0.00154	CcSEcCtD
Pasireotide—Fatigue—Dactinomycin—kidney cancer	0.00133	0.00154	CcSEcCtD
Pasireotide—Back pain—Paclitaxel—kidney cancer	0.0013	0.0015	CcSEcCtD
Pasireotide—Dizziness—Vinblastine—kidney cancer	0.0013	0.0015	CcSEcCtD
Pasireotide—Dizziness—Everolimus—kidney cancer	0.00129	0.00149	CcSEcCtD
Pasireotide—Abdominal pain—Sunitinib—kidney cancer	0.00129	0.00149	CcSEcCtD
Pasireotide—Diarrhoea—Erlotinib—kidney cancer	0.00129	0.00149	CcSEcCtD
Pasireotide—Hypotension—Vincristine—kidney cancer	0.00129	0.00149	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00126	0.00146	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.00126	0.00145	CcSEcCtD
Pasireotide—Insomnia—Vincristine—kidney cancer	0.00125	0.00144	CcSEcCtD
Pasireotide—Oedema peripheral—Capecitabine—kidney cancer	0.00125	0.00144	CcSEcCtD
Pasireotide—Vomiting—Vinblastine—kidney cancer	0.00125	0.00144	CcSEcCtD
Pasireotide—Dizziness—Erlotinib—kidney cancer	0.00124	0.00144	CcSEcCtD
Pasireotide—Vomiting—Everolimus—kidney cancer	0.00124	0.00144	CcSEcCtD
Pasireotide—Anaemia—Paclitaxel—kidney cancer	0.00124	0.00144	CcSEcCtD
Pasireotide—Headache—Vinblastine—kidney cancer	0.00123	0.00142	CcSEcCtD
Pasireotide—Headache—Everolimus—kidney cancer	0.00122	0.00142	CcSEcCtD
Pasireotide—Hypotension—Gemcitabine—kidney cancer	0.00122	0.00142	CcSEcCtD
Pasireotide—Abdominal pain—Dactinomycin—kidney cancer	0.00122	0.00141	CcSEcCtD
Pasireotide—Asthenia—Sorafenib—kidney cancer	0.00122	0.00141	CcSEcCtD
Pasireotide—Hypoglycaemia—Doxorubicin—kidney cancer	0.00121	0.0014	CcSEcCtD
Pasireotide—Vertigo—Paclitaxel—kidney cancer	0.00121	0.0014	CcSEcCtD
Pasireotide—Decreased appetite—Vincristine—kidney cancer	0.0012	0.00139	CcSEcCtD
Pasireotide—Pruritus—Sorafenib—kidney cancer	0.0012	0.00139	CcSEcCtD
Pasireotide—Vomiting—Erlotinib—kidney cancer	0.0012	0.00139	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00119	0.00138	CcSEcCtD
Pasireotide—Fatigue—Vincristine—kidney cancer	0.00119	0.00138	CcSEcCtD
Pasireotide—Insomnia—Gemcitabine—kidney cancer	0.00118	0.00137	CcSEcCtD
Pasireotide—Headache—Erlotinib—kidney cancer	0.00118	0.00137	CcSEcCtD
Pasireotide—Constipation—Vincristine—kidney cancer	0.00118	0.00137	CcSEcCtD
Pasireotide—Pain in extremity—Doxorubicin—kidney cancer	0.00118	0.00136	CcSEcCtD
Pasireotide—Asthenia—Sunitinib—kidney cancer	0.00117	0.00135	CcSEcCtD
Pasireotide—Nausea—Vinblastine—kidney cancer	0.00116	0.00135	CcSEcCtD
Pasireotide—Nausea—Everolimus—kidney cancer	0.00116	0.00134	CcSEcCtD
Pasireotide—Diarrhoea—Sorafenib—kidney cancer	0.00116	0.00134	CcSEcCtD
Pasireotide—Hypertension—Paclitaxel—kidney cancer	0.00116	0.00134	CcSEcCtD
Pasireotide—Pruritus—Sunitinib—kidney cancer	0.00115	0.00134	CcSEcCtD
Pasireotide—Arthralgia—Paclitaxel—kidney cancer	0.00114	0.00132	CcSEcCtD
Pasireotide—Myalgia—Paclitaxel—kidney cancer	0.00114	0.00132	CcSEcCtD
Pasireotide—Anxiety—Paclitaxel—kidney cancer	0.00114	0.00132	CcSEcCtD
Pasireotide—Decreased appetite—Gemcitabine—kidney cancer	0.00114	0.00132	CcSEcCtD
Pasireotide—Fatigue—Gemcitabine—kidney cancer	0.00113	0.00131	CcSEcCtD
Pasireotide—Gastrointestinal pain—Vincristine—kidney cancer	0.00113	0.00131	CcSEcCtD
Pasireotide—Dizziness—Sorafenib—kidney cancer	0.00112	0.0013	CcSEcCtD
Pasireotide—Constipation—Gemcitabine—kidney cancer	0.00112	0.0013	CcSEcCtD
Pasireotide—Nausea—Erlotinib—kidney cancer	0.00112	0.0013	CcSEcCtD
Pasireotide—Alopecia—Capecitabine—kidney cancer	0.00112	0.00129	CcSEcCtD
Pasireotide—Diarrhoea—Sunitinib—kidney cancer	0.00112	0.00129	CcSEcCtD
Pasireotide—Asthenia—Dactinomycin—kidney cancer	0.00111	0.00128	CcSEcCtD
Pasireotide—Abdominal pain—Vincristine—kidney cancer	0.00109	0.00126	CcSEcCtD
Pasireotide—Dry skin—Doxorubicin—kidney cancer	0.00108	0.00125	CcSEcCtD
Pasireotide—Dizziness—Sunitinib—kidney cancer	0.00108	0.00125	CcSEcCtD
Pasireotide—Vomiting—Sorafenib—kidney cancer	0.00108	0.00125	CcSEcCtD
Pasireotide—Abdominal pain upper—Doxorubicin—kidney cancer	0.00108	0.00125	CcSEcCtD
Pasireotide—Hypokalaemia—Doxorubicin—kidney cancer	0.00107	0.00124	CcSEcCtD
Pasireotide—Back pain—Capecitabine—kidney cancer	0.00106	0.00123	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00106	0.00123	CcSEcCtD
Pasireotide—Headache—Sorafenib—kidney cancer	0.00106	0.00123	CcSEcCtD
Pasireotide—Diarrhoea—Dactinomycin—kidney cancer	0.00106	0.00122	CcSEcCtD
Pasireotide—Nasopharyngitis—Doxorubicin—kidney cancer	0.00105	0.00122	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.00104	0.0012	CcSEcCtD
Pasireotide—Vomiting—Sunitinib—kidney cancer	0.00104	0.0012	CcSEcCtD
Pasireotide—Abdominal distension—Doxorubicin—kidney cancer	0.00103	0.00119	CcSEcCtD
Pasireotide—Hypotension—Paclitaxel—kidney cancer	0.00102	0.00118	CcSEcCtD
Pasireotide—Headache—Sunitinib—kidney cancer	0.00102	0.00118	CcSEcCtD
Pasireotide—Influenza—Doxorubicin—kidney cancer	0.00102	0.00118	CcSEcCtD
Pasireotide—Anaemia—Capecitabine—kidney cancer	0.00102	0.00118	CcSEcCtD
Pasireotide—Nausea—Sorafenib—kidney cancer	0.00101	0.00117	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000997	0.00116	CcSEcCtD
Pasireotide—Insomnia—Paclitaxel—kidney cancer	0.00099	0.00115	CcSEcCtD
Pasireotide—Vertigo—Capecitabine—kidney cancer	0.000989	0.00115	CcSEcCtD
Pasireotide—Asthenia—Vincristine—kidney cancer	0.000989	0.00115	CcSEcCtD
Pasireotide—Vomiting—Dactinomycin—kidney cancer	0.000981	0.00114	CcSEcCtD
Pasireotide—Nausea—Sunitinib—kidney cancer	0.000968	0.00112	CcSEcCtD
Pasireotide—Decreased appetite—Paclitaxel—kidney cancer	0.000952	0.0011	CcSEcCtD
Pasireotide—Hypertension—Capecitabine—kidney cancer	0.00095	0.0011	CcSEcCtD
Pasireotide—Fatigue—Paclitaxel—kidney cancer	0.000944	0.00109	CcSEcCtD
Pasireotide—Diarrhoea—Vincristine—kidney cancer	0.000943	0.00109	CcSEcCtD
Pasireotide—Asthenia—Gemcitabine—kidney cancer	0.000938	0.00109	CcSEcCtD
Pasireotide—Arthralgia—Capecitabine—kidney cancer	0.000937	0.00109	CcSEcCtD
Pasireotide—Myalgia—Capecitabine—kidney cancer	0.000937	0.00109	CcSEcCtD
Pasireotide—Constipation—Paclitaxel—kidney cancer	0.000936	0.00108	CcSEcCtD
Pasireotide—Anxiety—Capecitabine—kidney cancer	0.000934	0.00108	CcSEcCtD
Pasireotide—Pruritus—Gemcitabine—kidney cancer	0.000925	0.00107	CcSEcCtD
Pasireotide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000919	0.00106	CcSEcCtD
Pasireotide—Nausea—Dactinomycin—kidney cancer	0.000916	0.00106	CcSEcCtD
Pasireotide—Dizziness—Vincristine—kidney cancer	0.000912	0.00106	CcSEcCtD
Pasireotide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000895	0.00104	CcSEcCtD
Pasireotide—Diarrhoea—Gemcitabine—kidney cancer	0.000895	0.00104	CcSEcCtD
Pasireotide—Vomiting—Vincristine—kidney cancer	0.000876	0.00102	CcSEcCtD
Pasireotide—Abdominal pain—Paclitaxel—kidney cancer	0.000865	0.001	CcSEcCtD
Pasireotide—Headache—Vincristine—kidney cancer	0.000864	0.001	CcSEcCtD
Pasireotide—Hypotension—Capecitabine—kidney cancer	0.00084	0.000972	CcSEcCtD
Pasireotide—Vomiting—Gemcitabine—kidney cancer	0.000831	0.000963	CcSEcCtD
Pasireotide—Headache—Gemcitabine—kidney cancer	0.000819	0.000949	CcSEcCtD
Pasireotide—Nausea—Vincristine—kidney cancer	0.000819	0.000948	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000819	0.000948	CcSEcCtD
Pasireotide—Insomnia—Capecitabine—kidney cancer	0.000813	0.000941	CcSEcCtD
Pasireotide—Oedema peripheral—Doxorubicin—kidney cancer	0.000803	0.00093	CcSEcCtD
Pasireotide—Asthenia—Paclitaxel—kidney cancer	0.000786	0.00091	CcSEcCtD
Pasireotide—Decreased appetite—Capecitabine—kidney cancer	0.000781	0.000905	CcSEcCtD
Pasireotide—Nausea—Gemcitabine—kidney cancer	0.000777	0.0009	CcSEcCtD
Pasireotide—Fatigue—Capecitabine—kidney cancer	0.000775	0.000897	CcSEcCtD
Pasireotide—Pruritus—Paclitaxel—kidney cancer	0.000775	0.000897	CcSEcCtD
Pasireotide—Constipation—Capecitabine—kidney cancer	0.000768	0.00089	CcSEcCtD
Pasireotide—Diarrhoea—Paclitaxel—kidney cancer	0.000749	0.000868	CcSEcCtD
Pasireotide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000735	0.000851	CcSEcCtD
Pasireotide—Dizziness—Paclitaxel—kidney cancer	0.000724	0.000838	CcSEcCtD
Pasireotide—Alopecia—Doxorubicin—kidney cancer	0.00072	0.000834	CcSEcCtD
Pasireotide—Abdominal pain—Capecitabine—kidney cancer	0.00071	0.000823	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—AKAP13—kidney cancer	0.000707	0.00537	CbGpPWpGaD
Pasireotide—SSTR5—G alpha (i) signalling events—POMC—kidney cancer	0.000705	0.00535	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—LATS1—kidney cancer	0.0007	0.00531	CbGpPWpGaD
Pasireotide—Vomiting—Paclitaxel—kidney cancer	0.000696	0.000806	CcSEcCtD
Pasireotide—SSTR1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000693	0.00526	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—ITPR2—kidney cancer	0.000691	0.00524	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKAP13—kidney cancer	0.000691	0.00524	CbGpPWpGaD
Pasireotide—Back pain—Doxorubicin—kidney cancer	0.000686	0.000795	CcSEcCtD
Pasireotide—Headache—Paclitaxel—kidney cancer	0.000686	0.000794	CcSEcCtD
Pasireotide—SSTR1—GPCR downstream signaling—ITPR2—kidney cancer	0.000662	0.00503	CbGpPWpGaD
Pasireotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000659	0.005	CbGpPWpGaD
Pasireotide—Anaemia—Doxorubicin—kidney cancer	0.000656	0.00076	CcSEcCtD
Pasireotide—SSTR2—G alpha (i) signalling events—POMC—kidney cancer	0.00065	0.00494	CbGpPWpGaD
Pasireotide—Nausea—Paclitaxel—kidney cancer	0.00065	0.000753	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000649	0.00493	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AMER1—kidney cancer	0.000645	0.0049	CbGpPWpGaD
Pasireotide—Asthenia—Capecitabine—kidney cancer	0.000645	0.000747	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000644	0.00489	CbGpPWpGaD
Pasireotide—Vertigo—Doxorubicin—kidney cancer	0.000638	0.000738	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—AKAP13—kidney cancer	0.000637	0.00484	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CER1—kidney cancer	0.000636	0.00483	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—GPC3—kidney cancer	0.000636	0.00483	CbGpPWpGaD
Pasireotide—Pruritus—Capecitabine—kidney cancer	0.000636	0.000736	CcSEcCtD
Pasireotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000632	0.0048	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—ITPR2—kidney cancer	0.000627	0.00476	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKAP13—kidney cancer	0.000627	0.00476	CbGpPWpGaD
Pasireotide—Diarrhoea—Capecitabine—kidney cancer	0.000615	0.000712	CcSEcCtD
Pasireotide—Hypertension—Doxorubicin—kidney cancer	0.000613	0.00071	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—GPC3—kidney cancer	0.00061	0.00463	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CER1—kidney cancer	0.00061	0.00463	CbGpPWpGaD
Pasireotide—Arthralgia—Doxorubicin—kidney cancer	0.000604	0.0007	CcSEcCtD
Pasireotide—Myalgia—Doxorubicin—kidney cancer	0.000604	0.0007	CcSEcCtD
Pasireotide—Anxiety—Doxorubicin—kidney cancer	0.000602	0.000697	CcSEcCtD
Pasireotide—SSTR1—Signaling by GPCR—ITPR2—kidney cancer	0.000601	0.00456	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AMER1—kidney cancer	0.000595	0.00452	CbGpPWpGaD
Pasireotide—Dizziness—Capecitabine—kidney cancer	0.000594	0.000688	CcSEcCtD
Pasireotide—SSTR5—GPCR downstream signaling—ITPR2—kidney cancer	0.000587	0.00446	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKAP13—kidney cancer	0.000579	0.00439	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—ANXA1—kidney cancer	0.000579	0.00439	CbGpPWpGaD
Pasireotide—Vomiting—Capecitabine—kidney cancer	0.000571	0.000662	CcSEcCtD
Pasireotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000567	0.0043	CbGpPWpGaD
Pasireotide—Headache—Capecitabine—kidney cancer	0.000563	0.000652	CcSEcCtD
Pasireotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.00056	0.00425	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—ANXA1—kidney cancer	0.000555	0.00421	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—ITPR2—kidney cancer	0.000542	0.00411	CbGpPWpGaD
Pasireotide—Hypotension—Doxorubicin—kidney cancer	0.000541	0.000627	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—SFRP2—kidney cancer	0.000541	0.0041	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GPC3—kidney cancer	0.000541	0.0041	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CER1—kidney cancer	0.000541	0.0041	CbGpPWpGaD
Pasireotide—Nausea—Capecitabine—kidney cancer	0.000534	0.000618	CcSEcCtD
Pasireotide—SSTR5—Signaling by GPCR—ITPR2—kidney cancer	0.000533	0.00405	CbGpPWpGaD
Pasireotide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000528	0.000611	CcSEcCtD
Pasireotide—SSTR3—Signaling by GPCR—ANXA1—kidney cancer	0.000526	0.00399	CbGpPWpGaD
Pasireotide—Insomnia—Doxorubicin—kidney cancer	0.000524	0.000607	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—SFRP2—kidney cancer	0.000518	0.00393	CbGpPWpGaD
Pasireotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	0.000517	0.00392	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—ANXA1—kidney cancer	0.000504	0.00382	CbGpPWpGaD
Pasireotide—Decreased appetite—Doxorubicin—kidney cancer	0.000503	0.000583	CcSEcCtD
Pasireotide—SSTR3—GPCR ligand binding—POMC—kidney cancer	0.000502	0.00381	CbGpPWpGaD
Pasireotide—Fatigue—Doxorubicin—kidney cancer	0.000499	0.000578	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CER1—kidney cancer	0.000499	0.00379	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GPC3—kidney cancer	0.000499	0.00379	CbGpPWpGaD
Pasireotide—Constipation—Doxorubicin—kidney cancer	0.000495	0.000574	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—ITPR2—kidney cancer	0.000492	0.00374	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—ANXA1—kidney cancer	0.000492	0.00374	CbGpPWpGaD
Pasireotide—SSTR1—GPCR ligand binding—POMC—kidney cancer	0.000481	0.00365	CbGpPWpGaD
Pasireotide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000474	0.000548	CcSEcCtD
Pasireotide—SSTR5—Signaling Pathways—SFRP2—kidney cancer	0.00046	0.00349	CbGpPWpGaD
Pasireotide—Abdominal pain—Doxorubicin—kidney cancer	0.000458	0.00053	CcSEcCtD
Pasireotide—SSTR2—GPCR downstream signaling—ANXA1—kidney cancer	0.000454	0.00345	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—ANXA1—kidney cancer	0.000447	0.00339	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKAP13—kidney cancer	0.000436	0.00331	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP2—kidney cancer	0.000436	0.00331	CbGpPWpGaD
Pasireotide—SSTR5—GPCR ligand binding—POMC—kidney cancer	0.000427	0.00324	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SFRP2—kidney cancer	0.000424	0.00322	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP2—kidney cancer	0.000418	0.00317	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKAP13—kidney cancer	0.000418	0.00317	CbGpPWpGaD
Pasireotide—Asthenia—Doxorubicin—kidney cancer	0.000416	0.000481	CcSEcCtD
Pasireotide—SSTR2—Signaling by GPCR—ANXA1—kidney cancer	0.000412	0.00313	CbGpPWpGaD
Pasireotide—Pruritus—Doxorubicin—kidney cancer	0.00041	0.000475	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—GRB7—kidney cancer	0.000399	0.00303	CbGpPWpGaD
Pasireotide—Diarrhoea—Doxorubicin—kidney cancer	0.000396	0.000459	CcSEcCtD
Pasireotide—SSTR2—GPCR ligand binding—POMC—kidney cancer	0.000394	0.00299	CbGpPWpGaD
Pasireotide—Dizziness—Doxorubicin—kidney cancer	0.000383	0.000444	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—GRB7—kidney cancer	0.000382	0.0029	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKAP13—kidney cancer	0.000371	0.00281	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ITPR2—kidney cancer	0.000371	0.00281	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP2—kidney cancer	0.000371	0.00281	CbGpPWpGaD
Pasireotide—Vomiting—Doxorubicin—kidney cancer	0.000368	0.000426	CcSEcCtD
Pasireotide—Headache—Doxorubicin—kidney cancer	0.000363	0.00042	CcSEcCtD
Pasireotide—SSTR1—Signaling Pathways—ITPR2—kidney cancer	0.000355	0.0027	CbGpPWpGaD
Pasireotide—Nausea—Doxorubicin—kidney cancer	0.000344	0.000398	CcSEcCtD
Pasireotide—SSTR2—Signaling Pathways—CASP2—kidney cancer	0.000342	0.0026	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKAP13—kidney cancer	0.000342	0.0026	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—GRB7—kidney cancer	0.000339	0.00257	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNA1—kidney cancer	0.000336	0.00255	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EIF4EBP1—kidney cancer	0.000334	0.00254	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HSPB1—kidney cancer	0.000334	0.00254	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNA1—kidney cancer	0.000322	0.00244	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EIF4EBP1—kidney cancer	0.00032	0.00243	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HSPB1—kidney cancer	0.00032	0.00243	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ITPR2—kidney cancer	0.000315	0.00239	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—GRB7—kidney cancer	0.000313	0.00237	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PSMD7—kidney cancer	0.000311	0.00236	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSC1—kidney cancer	0.000311	0.00236	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ANXA1—kidney cancer	0.000311	0.00236	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FLT1—kidney cancer	0.000301	0.00228	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSC1—kidney cancer	0.000298	0.00226	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PSMD7—kidney cancer	0.000298	0.00226	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ANXA1—kidney cancer	0.000298	0.00226	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ITPR2—kidney cancer	0.000291	0.00221	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FLT1—kidney cancer	0.000288	0.00219	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNA1—kidney cancer	0.000286	0.00217	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HSPB1—kidney cancer	0.000284	0.00216	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EIF4EBP1—kidney cancer	0.000284	0.00216	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—POMC—kidney cancer	0.000284	0.00215	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUNB—kidney cancer	0.000279	0.00212	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PAK1—kidney cancer	0.000279	0.00212	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—POMC—kidney cancer	0.000272	0.00206	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUNB—kidney cancer	0.000267	0.00203	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PAK1—kidney cancer	0.000267	0.00203	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ANXA1—kidney cancer	0.000264	0.002	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSC1—kidney cancer	0.000264	0.002	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PSMD7—kidney cancer	0.000264	0.002	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNA1—kidney cancer	0.000264	0.002	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HSPB1—kidney cancer	0.000262	0.00199	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EIF4EBP1—kidney cancer	0.000262	0.00199	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—POMC—kidney cancer	0.000258	0.00195	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FLT1—kidney cancer	0.000256	0.00194	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—POMC—kidney cancer	0.000247	0.00187	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PSMD7—kidney cancer	0.000244	0.00185	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSC1—kidney cancer	0.000244	0.00185	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ANXA1—kidney cancer	0.000244	0.00185	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—POMC—kidney cancer	0.000241	0.00183	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUNB—kidney cancer	0.000237	0.0018	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PAK1—kidney cancer	0.000237	0.0018	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FLT1—kidney cancer	0.000236	0.00179	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF2—kidney cancer	0.000228	0.00173	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN2B—kidney cancer	0.000227	0.00172	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—POMC—kidney cancer	0.000223	0.00169	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF1R—kidney cancer	0.00022	0.00167	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—POMC—kidney cancer	0.000219	0.00166	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUNB—kidney cancer	0.000219	0.00166	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PAK1—kidney cancer	0.000219	0.00166	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF2—kidney cancer	0.000218	0.00166	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN2B—kidney cancer	0.000218	0.00165	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—RAF1—kidney cancer	0.000212	0.00161	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF1R—kidney cancer	0.000211	0.0016	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—IL2—kidney cancer	0.00021	0.00159	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—RAF1—kidney cancer	0.000204	0.00155	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—POMC—kidney cancer	0.000202	0.00153	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—IL2—kidney cancer	0.000201	0.00153	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF2—kidney cancer	0.000194	0.00147	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN2B—kidney cancer	0.000193	0.00146	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL2—kidney cancer	0.00019	0.00144	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1R—kidney cancer	0.000187	0.00142	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—kidney cancer	0.000183	0.00139	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HIF1A—kidney cancer	0.000181	0.00138	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TSC2—kidney cancer	0.000181	0.00137	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—RAF1—kidney cancer	0.000181	0.00137	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF2—kidney cancer	0.000179	0.00136	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—kidney cancer	0.000178	0.00135	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN2B—kidney cancer	0.000178	0.00135	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HIF1A—kidney cancer	0.000174	0.00132	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KDR—kidney cancer	0.000173	0.00132	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TSC2—kidney cancer	0.000173	0.00132	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1R—kidney cancer	0.000173	0.00131	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—RAF1—kidney cancer	0.000167	0.00126	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KDR—kidney cancer	0.000166	0.00126	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—kidney cancer	0.000165	0.00125	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—kidney cancer	0.000162	0.00123	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APC—kidney cancer	0.00016	0.00121	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KIT—kidney cancer	0.00016	0.00121	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HIF1A—kidney cancer	0.000154	0.00117	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TSC2—kidney cancer	0.000154	0.00117	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KIT—kidney cancer	0.000153	0.00116	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APC—kidney cancer	0.000153	0.00116	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK3—kidney cancer	0.000153	0.00116	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—POMC—kidney cancer	0.000152	0.00115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BRAF—kidney cancer	0.00015	0.00114	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—kidney cancer	0.000149	0.00113	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KDR—kidney cancer	0.000148	0.00112	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK3—kidney cancer	0.000147	0.00111	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—POMC—kidney cancer	0.000146	0.00111	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK1—kidney cancer	0.000146	0.00111	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BRAF—kidney cancer	0.000144	0.00109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HIF1A—kidney cancer	0.000142	0.00108	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TSC2—kidney cancer	0.000142	0.00108	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK1—kidney cancer	0.00014	0.00106	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—kidney cancer	0.000139	0.00106	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—KRAS—kidney cancer	0.000138	0.00104	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KDR—kidney cancer	0.000136	0.00103	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KIT—kidney cancer	0.000136	0.00103	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APC—kidney cancer	0.000136	0.00103	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—kidney cancer	0.000133	0.00101	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—KRAS—kidney cancer	0.000132	0.001	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK3—kidney cancer	0.00013	0.000988	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—POMC—kidney cancer	0.000129	0.000982	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BRAF—kidney cancer	0.000128	0.000969	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—kidney cancer	0.000126	0.000959	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAF1—kidney cancer	0.000125	0.000952	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KIT—kidney cancer	0.000125	0.000952	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APC—kidney cancer	0.000125	0.000952	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RELA—kidney cancer	0.000125	0.000948	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ERBB2—kidney cancer	0.000124	0.000942	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK1—kidney cancer	0.000124	0.00094	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MTOR—kidney cancer	0.000122	0.000929	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—kidney cancer	0.000121	0.00092	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAF1—kidney cancer	0.00012	0.000913	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK3—kidney cancer	0.00012	0.000912	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RELA—kidney cancer	0.00012	0.000909	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—POMC—kidney cancer	0.000119	0.000906	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ERBB2—kidney cancer	0.000119	0.000903	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—kidney cancer	0.000118	0.000898	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BRAF—kidney cancer	0.000118	0.000895	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MTOR—kidney cancer	0.000117	0.000891	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—KRAS—kidney cancer	0.000117	0.000888	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1B—kidney cancer	0.000115	0.000872	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK1—kidney cancer	0.000114	0.000867	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—kidney cancer	0.000112	0.000854	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1B—kidney cancer	0.00011	0.000836	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—kidney cancer	0.00011	0.000832	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—JUN—kidney cancer	0.000109	0.00083	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—kidney cancer	0.000109	0.000829	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNB1—kidney cancer	0.000109	0.000824	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—KRAS—kidney cancer	0.000108	0.000819	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—kidney cancer	0.000108	0.000818	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—kidney cancer	0.000107	0.000816	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAF1—kidney cancer	0.000107	0.000809	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RELA—kidney cancer	0.000106	0.000806	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTEN—kidney cancer	0.000106	0.000803	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB2—kidney cancer	0.000106	0.000801	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—kidney cancer	0.000105	0.000798	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—JUN—kidney cancer	0.000105	0.000796	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MTOR—kidney cancer	0.000104	0.00079	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNB1—kidney cancer	0.000104	0.00079	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTEN—kidney cancer	0.000101	0.00077	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—kidney cancer	9.92e-05	0.000753	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAF1—kidney cancer	9.84e-05	0.000747	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RELA—kidney cancer	9.8e-05	0.000744	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1B—kidney cancer	9.77e-05	0.000742	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB2—kidney cancer	9.74e-05	0.000739	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MTOR—kidney cancer	9.61e-05	0.000729	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—kidney cancer	9.56e-05	0.000726	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—kidney cancer	9.56e-05	0.000725	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—kidney cancer	9.32e-05	0.000708	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—JUN—kidney cancer	9.3e-05	0.000706	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNB1—kidney cancer	9.23e-05	0.000701	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—kidney cancer	9.16e-05	0.000695	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK3—kidney cancer	9.04e-05	0.000686	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1B—kidney cancer	9.02e-05	0.000684	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTEN—kidney cancer	9e-05	0.000683	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—kidney cancer	8.82e-05	0.00067	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—kidney cancer	8.79e-05	0.000667	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK3—kidney cancer	8.67e-05	0.000658	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK1—kidney cancer	8.6e-05	0.000653	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—kidney cancer	8.6e-05	0.000653	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—JUN—kidney cancer	8.58e-05	0.000652	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNB1—kidney cancer	8.52e-05	0.000647	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—kidney cancer	8.43e-05	0.00064	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTEN—kidney cancer	8.3e-05	0.00063	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK1—kidney cancer	8.25e-05	0.000626	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—kidney cancer	8.13e-05	0.000617	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KRAS—kidney cancer	8.13e-05	0.000617	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KRAS—kidney cancer	7.79e-05	0.000591	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK3—kidney cancer	7.69e-05	0.000583	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—kidney cancer	7.5e-05	0.000569	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—kidney cancer	7.48e-05	0.000568	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—kidney cancer	7.47e-05	0.000567	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK1—kidney cancer	7.31e-05	0.000555	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—kidney cancer	7.22e-05	0.000548	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—kidney cancer	7.16e-05	0.000543	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK3—kidney cancer	7.09e-05	0.000538	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—kidney cancer	6.92e-05	0.000526	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KRAS—kidney cancer	6.91e-05	0.000524	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—kidney cancer	6.9e-05	0.000524	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK1—kidney cancer	6.75e-05	0.000512	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KRAS—kidney cancer	6.38e-05	0.000484	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—kidney cancer	6.35e-05	0.000482	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—kidney cancer	6.14e-05	0.000466	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—kidney cancer	5.86e-05	0.000445	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—kidney cancer	5.67e-05	0.00043	CbGpPWpGaD
